Site notifications

Sub menu

 

 

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset for information on the evaluation of prescription medicines.

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Topics

AusPAR Date

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

1125 result(s) found, displaying 651 to 675

  • AusPAR: Pirfenidone

    Australian public assessment report (AusPar)
    Australian Assessment Report for Pirfenidone

  • AusPAR: Pertuzumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Pertuzumab

  • AusPAR: Gliclazide

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Gliclazide

  • AusPAR: Adalimumab (rch)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Adalimumab (rch)

  • AusPAR: Asfotase alfa (rch)

    Australian public assessment report (AusPar)
    Australian public assessment report for Asfotase alfa (rch)

  • AusPAR: Alprostadil

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Alprostadil

  • AusPAR: Omalizumab (rch)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Omalizumab (rch)

  • AusPAR: Simoctocog alfa rhu

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Simoctocog alfa rhu

  • AusPAR: Armodafinil

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Armodafinil

  • AusPAR: Naloxegol oxalate

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Naloxegol oxolate

  • AusPAR: Evolocumab (rch)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Evolocumab (rch)

  • AusPAR: Eltrombopag

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Eltrombopag

  • AusPAR: Liraglutide

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Liraglutide

  • AusPAR: Ibrutinib

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Ibrutinib

  • AusPAR: Enzalutamide

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for enzalutamide

  • AusPAR: Bortezomib

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Bortezomib

  • AusPAR: Lipegfilgrastim (rbe)

    Australian public assessment report (AusPar)
    Australian public assessment report for Lipegfilgrastim (rbe)

  • AusPAR: Nintedanib esilate

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Nintedanib esilate

  • AusPAR: Budesonide

    Australian public assessment report (AusPar)
    Australian public assessment report for Budesonide